Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 10/2014

Open Access 01-10-2014 | Nephrology - Review

Factors that can minimize bleeding complications after renal biopsy

Authors: M. S. Zhu, J. Z. Chen, A. P. Xu

Published in: International Urology and Nephrology | Issue 10/2014

Login to get access

Abstract

Renal biopsy is a very important diagnostic tool in the evaluation of renal diseases. However, bleeding remains to be one of the most serious complications in this procedure. Many new techniques have been improved to make it safer. The risk factors and predictors of bleeding after percutaneous renal biopsy have been extensively reported in many literatures, and generally speaking, the common risk factors for renal biopsy complications focus on hypertension, high serum creatinine, bleeding diatheses, amyloidosis, advanced age, gender and so on. Our primary purpose of this review is to summarize current measures in recent years literature aiming at minimizing the bleeding complication after the renal biopsy, including the drug application before and after renal biopsy, operation details in percutaneous renal biopsies, nursing and close monitoring after the biopsy and other kinds of biopsy methods.
Literature
1.
Shidham GB, Siddiqi N, Beres JA et al (2005) Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton) 10:305–310CrossRef
2.
Waldo B, Korbet SM, Freimanis MG, Lewis EJ (2009) The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrol Dial Transplant 24:2433–2439PubMedCrossRef
3.
Stratta P, Canavese C, Marengo M, Mesiano P et al (2007) Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest 37:954–963PubMedCrossRef
4.
Ishikawa E, Nomura S, Hamaguchi T et al (2009) Ultrasonography as a predictor of overt bleeding after renal biopsy. Clin Exp Nephrol 13:325–331PubMedCrossRef
5.
6.
Fish Richard, Pinney Jennifer, Jain Poorva et al (2010) The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol 5:1977–1980PubMedCrossRefPubMedCentral
7.
Corapi KM, Chen JL, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60(1):62–73PubMedCrossRef
8.
Daram Sumanth R, Reddivari Venkata, Bastani Bahar (2010) Bleeding complications associated with percutaneous renal biopsy using Biopince needle. Int Urol Nephrol 42:841–842PubMedCrossRef
9.
Tondel C, Vikse BE, Bostad L, Svarstad E (2012) Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988–2010. Clin J Am Soc Nephrol. 7(10):1591–1597PubMedCrossRefPubMedCentral
10.
Whittier WL, Korbet SM (2004) Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 15:142–147PubMedCrossRef
11.
Munoz AT, Valdez-Ortiz R, González-Parra C et al (2011) Percutaneous renal biopsy of native kidneys: efficiency, safety and risk factors associated with major complications. Arch Med Sci 7(5):823–831CrossRef
12.
Mackinnon B, Fraser E, Simpson K et al (2008) Is it necessary to stop antiplatelet agents before a native renal biopsy? Nephrol Dial Transplant 23:3566–3570PubMedCrossRef
13.
van den Hoogen MW, Verbruggen BW, Polenewen R, Hilbrands LB, Nováková IR (2009) Use of the platelet function analyzer to minimize bleeding complications after renal biopsy. Thromb Res 123:515–522
14.
Fisi Viktoria, Mazak Istvan, Degrell Peter et al (2012) Histological diagnosis determines complications of percutaneous renal biopsy: a single-center experience in 353 patients. Kidney Blood Press Res 35:26–34PubMedCrossRef
15.
Soares SM, Fervenza FC, Lager DJ et al (2008) Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis 52:1079–1083PubMedCrossRef
16.
Kohli HS, Jairam A, Bhat A et al (2006) Safety of kidney biopsy in elderly: a prospective study. Int Urol Nephrol 38:815–820PubMedCrossRef
17.
Bollee G, Martinez F, Moulin B et al (2010) Renal biopsy practice in France: results of a nationwide study. Nephrol Dial Transpl 25:3579–3585CrossRef
18.
Manno C, Bonifati C, Torres DD et al (2011) Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis 57(6):850–855PubMedCrossRef
19.
Maksimovic Bojana, Neretljak Ivan, Vidas Zeljko et al (2012) Treatment of bleeding after kidney biopsy with recombinant activated factor VII. Blood Coagul Fibrinolysis 23:241–243PubMedCrossRef
20.
Feng H (2009) The clinical observation of the effect of preventative use of hematostasis drugs on the post-renal biopsy bleeding. Chin J Mod Drug App 3(22):87–88
21.
Zhou G (2011) The influence of different preventative measures on the post-renal biopsy bleeding. Chin J Gen Pract 9(11):1732–1733
22.
Atwell TD, Smith RL, Hesley GK et al (2010) Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. AJR 194:784–789PubMedCrossRef
23.
Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Intern Med 257(5):399–414PubMedCrossRef
24.
Kim D, Kim H, Shin G et al (1998) A randomized, prospective, comparative study of manual and automated renal biopsies. Am J Kidney Dis 32:426–431PubMedCrossRef
25.
Eiro M, Katoh T, Watanabe T (2005) Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 9:40–45PubMedCrossRef
26.
Pasquariello A, Innocenti M, Batini V et al (2007) Theoretical calculation of optimal depth in the percutaneous native kidney biopsy to drastically reduce bleeding complications and sample inadequacy for histopatho-logical diagnosis. Nephrol Dial Transplant 22:3516–3520PubMedCrossRef
27.
Maya ID, Maddela P, Barker J, Allon M (2007) Percutaneous renal biopsy: comparison of blind and real-time ultrasound-guided technique. Semin Dial 20(4):355–358PubMedCrossRef
28.
Yuan HH, et al. (2008) The reassess of the effect of vitamin K1 on the post-renal biopsy bleeding. Med J West China 20(1):100–101
29.
Li MP et al. (2006) The risk factors and nursing measures of the percutaneous renal biopsy complications. J Guangdong Med Coll 24(2):221–222
30.
Uppot RN, Harisinghani MG, Gervais DA (2010) Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 194:1443–1449PubMedCrossRef
31.
Manno C, Strippoli GF, Arnesano L et al (2004) Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66:1570–1577PubMedCrossRef
32.
33.
See TC, Thompson BC et al (2008) Transjugular renal biopsy: our experience and technical considerations. Cardiovasc Intervent Radiol 31:906–918PubMedCrossRef
34.
Cluzel P, Martinez F, Bellin MF et al (2000) Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology 215:689–693PubMedCrossRef
35.
Levi IM, Ben-Dov IZ, Klimov A et al (2011) Transjugular kidney biopsy: enabling safe tissue diagnosis in high risk patients. IMAJ 13:425–427PubMed
36.
Peces R, de Sousa E, Peces C (2011) Renal biopsies in special situations. Nefrologia 31(6):627–629PubMed
37.
Leal JJ (1993) A new technique for renal biopsy: the transurethral approach. J Urol 149:1061–1063PubMed
Metadata
Title
Factors that can minimize bleeding complications after renal biopsy
Authors
M. S. Zhu
J. Z. Chen
A. P. Xu
Publication date
01-10-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0560-6

Other articles of this Issue 10/2014

International Urology and Nephrology 10/2014 Go to the issue

Nephrology – Original Paper

AKI in early sepsis is a continuum from transient AKI without tubular damage over transient AKI with minor tubular damage to intrinsic AKI with severe tubular damage

Urology - Original Paper

Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients

Urology - Original Paper

Effects of the recreational use of PDE5 inhibitors on the corpus cavernosum of young, healthy rats

Nephrology - Original Paper

Effect of continuous positive airway pressure on serum cystatin C among obstructive sleep apnea syndrome patients

Urology - Original Paper

Ureteroscopic lithotripsy in Trendelenburg position for proximal ureteral calculi: a prospective, randomized, comparative study

Urology - Original Paper

Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits